Syntiron, LLC
1000 Westgate Drive
Suite 152
St Paul, Minnesota 55114
Phone: (651) 641-2876
Fax: (651) 641-2877
Contact: Amber McKinzie
Biomedical/Bioscience Field
Pre-clinical vaccine development
Business
Development stage
Products and Services
Syntiron is a biopharmaceutical company that is developing vaccines and immuno-therapeutics for the prevention and treatment of bacterial diseases, including
- hospital-acquired (nosocomial) infections
- food and waterborne infections (including traveler's diarrhea)
- bacterial biowarfare agents
- urinary tract infections, and
- wound infections.
Syntiron's patented vaccine technology is based on the use of defined bacterial cell-surface components as target antigens for vaccine and immunotherapeutic development. This technology has been successfully established for use in veterinary healthcare. Syntiron is currently developing the technology for several areas of human healthcare.
Technical Support Contact
Syntiron Homepage